12 
applied genetics and of contract proposals for Mini-Assessment of Potentially 
Significant Future Environmental Problems, including "Applied Genetics: 
Industrial" and "Applied Genetics: Agriculture," 
Dr. Omenn placed the following four Items on the agenda for the 
September 4 Subcommittee meeting: 
1. NIOSH should present illustrative material on worker education 
about biotechnologies, as assembled from Its site visits and from material 
the Pharmaceutical Manufacturers Association will supply. 
2. Illustrative examples should be presented by Subcommittee members 
including FDA, DOC, USDA and NIOSH as to the hazard of making the same product 
by recombinant DNA as compared to other methods. Dr. Goldberg's distinction 
of product versus process is important. The Subcommittee must look beyond 
recombinant DNA to the broader context of biohazards to convince itself that 
the priority in focusing on recombinant DNA is correct, 
3. NIOSH should have further Information on the progress it has made 
in eval uati ng the ei ght items cited in Dr. Robbins' June 11 memorandum. 
4. EPA should report on its activities. 
Additional agenda items may be suggested by Subcommittee members to Dr, Talbot. 
Bernard Talbot, M.D., Ph.D, 
Subcommittee Executive Secretary 
June 20, 1980 
[ 366 ] 
